Merck obtains right to experimental Ebola vaccine
November 24, 2014 at 11:23 AM EST
NewLink Genetics to receive $30 million upfront, plus an additional $20 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.